Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(efflux transporters). Showing records 1 – 17 of 17 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


Universidade do Rio Grande do Sul

1. Zimmermann, Estevan Sonego. Modelagem farmacocinética populacional na avaliação do papel da glicoproteína-P na penetração tecidual de fluoroquinolonas.

Degree: 2015, Universidade do Rio Grande do Sul

 Objetivos: O objetivo deste trabalho foi desenvolver modelo farmacocinético (popPK) populacional para descrever simultaneamente as concentrações das fluoroquinolonas (levofloxacino – LEV e ciprofloxacino – CIP)… (more)

Subjects/Keywords: Fluoroquinolones; Fluoroquinolonas; Farmacocinética; Pharmacokinetic; Efflux transporters; PopPK modeling; Microdialysis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zimmermann, E. S. (2015). Modelagem farmacocinética populacional na avaliação do papel da glicoproteína-P na penetração tecidual de fluoroquinolonas. (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/163764

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Zimmermann, Estevan Sonego. “Modelagem farmacocinética populacional na avaliação do papel da glicoproteína-P na penetração tecidual de fluoroquinolonas.” 2015. Thesis, Universidade do Rio Grande do Sul. Accessed March 07, 2021. http://hdl.handle.net/10183/163764.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Zimmermann, Estevan Sonego. “Modelagem farmacocinética populacional na avaliação do papel da glicoproteína-P na penetração tecidual de fluoroquinolonas.” 2015. Web. 07 Mar 2021.

Vancouver:

Zimmermann ES. Modelagem farmacocinética populacional na avaliação do papel da glicoproteína-P na penetração tecidual de fluoroquinolonas. [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2015. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/10183/163764.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Zimmermann ES. Modelagem farmacocinética populacional na avaliação do papel da glicoproteína-P na penetração tecidual de fluoroquinolonas. [Thesis]. Universidade do Rio Grande do Sul; 2015. Available from: http://hdl.handle.net/10183/163764

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Arizona

2. Kim, Eun-Hae. Maintaining Copper Homeostasis - Molecular Studies on Bacterial Copper Transporters .

Degree: 2011, University of Arizona

 Bacteria have evolved sophisticated cellular transport mechanisms to maintain metal homeostasis to not only utilize metals as important cofactors but also to evade the toxicity… (more)

Subjects/Keywords: HME; metal; RND; transporters; Soil, Water & Environmental Science; copper; efflux

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kim, E. (2011). Maintaining Copper Homeostasis - Molecular Studies on Bacterial Copper Transporters . (Doctoral Dissertation). University of Arizona. Retrieved from http://hdl.handle.net/10150/205232

Chicago Manual of Style (16th Edition):

Kim, Eun-Hae. “Maintaining Copper Homeostasis - Molecular Studies on Bacterial Copper Transporters .” 2011. Doctoral Dissertation, University of Arizona. Accessed March 07, 2021. http://hdl.handle.net/10150/205232.

MLA Handbook (7th Edition):

Kim, Eun-Hae. “Maintaining Copper Homeostasis - Molecular Studies on Bacterial Copper Transporters .” 2011. Web. 07 Mar 2021.

Vancouver:

Kim E. Maintaining Copper Homeostasis - Molecular Studies on Bacterial Copper Transporters . [Internet] [Doctoral dissertation]. University of Arizona; 2011. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/10150/205232.

Council of Science Editors:

Kim E. Maintaining Copper Homeostasis - Molecular Studies on Bacterial Copper Transporters . [Doctoral Dissertation]. University of Arizona; 2011. Available from: http://hdl.handle.net/10150/205232


University of Adelaide

3. Pederick, Victoria Grace. Characterisation of the ATP-binding cassette transporters of Pseudomonas aeruginosa.

Degree: 2015, University of Adelaide

 Pseudomonas aeruginosa is a ubiquitous, Gram-negative, rod-shaped, environmental bacterium. However, it is also a clinically significant, opportunistic human pathogen, responsible for life-threatening infections in immunocompromised… (more)

Subjects/Keywords: pseudomonas aeruginosa; ABC transporters; zinc; molybdenum; metal ion import; drug efflux

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pederick, V. G. (2015). Characterisation of the ATP-binding cassette transporters of Pseudomonas aeruginosa. (Thesis). University of Adelaide. Retrieved from http://hdl.handle.net/2440/106301

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Pederick, Victoria Grace. “Characterisation of the ATP-binding cassette transporters of Pseudomonas aeruginosa.” 2015. Thesis, University of Adelaide. Accessed March 07, 2021. http://hdl.handle.net/2440/106301.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Pederick, Victoria Grace. “Characterisation of the ATP-binding cassette transporters of Pseudomonas aeruginosa.” 2015. Web. 07 Mar 2021.

Vancouver:

Pederick VG. Characterisation of the ATP-binding cassette transporters of Pseudomonas aeruginosa. [Internet] [Thesis]. University of Adelaide; 2015. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/2440/106301.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Pederick VG. Characterisation of the ATP-binding cassette transporters of Pseudomonas aeruginosa. [Thesis]. University of Adelaide; 2015. Available from: http://hdl.handle.net/2440/106301

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Minnesota

4. Laramy, Janice. Permeability, binding and distributional kinetics of Ponatinib, a multi-kinase inhibitor: implications for the treatment of brain tumors.

Degree: PhD, Pharmaceutics, 2018, University of Minnesota

 Glioblastoma (GBM) is the most common malignant brain tumor and one of the unmet medical needs. Among over 1,000 GBM clinical trials testing molecularly-targeted agents,… (more)

Subjects/Keywords: Blood-brain barrier; Efflux transporters; Glioblastoma; Tyrosine kinase inhibitor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Laramy, J. (2018). Permeability, binding and distributional kinetics of Ponatinib, a multi-kinase inhibitor: implications for the treatment of brain tumors. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/213085

Chicago Manual of Style (16th Edition):

Laramy, Janice. “Permeability, binding and distributional kinetics of Ponatinib, a multi-kinase inhibitor: implications for the treatment of brain tumors.” 2018. Doctoral Dissertation, University of Minnesota. Accessed March 07, 2021. http://hdl.handle.net/11299/213085.

MLA Handbook (7th Edition):

Laramy, Janice. “Permeability, binding and distributional kinetics of Ponatinib, a multi-kinase inhibitor: implications for the treatment of brain tumors.” 2018. Web. 07 Mar 2021.

Vancouver:

Laramy J. Permeability, binding and distributional kinetics of Ponatinib, a multi-kinase inhibitor: implications for the treatment of brain tumors. [Internet] [Doctoral dissertation]. University of Minnesota; 2018. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/11299/213085.

Council of Science Editors:

Laramy J. Permeability, binding and distributional kinetics of Ponatinib, a multi-kinase inhibitor: implications for the treatment of brain tumors. [Doctoral Dissertation]. University of Minnesota; 2018. Available from: http://hdl.handle.net/11299/213085


University of California – Berkeley

5. Boyarskiy, Sergey. Small molecule membrane transporters for enhanced microbial production of biochemicals.

Degree: Bioengineering, 2015, University of California – Berkeley

 Metabolic engineering has been applied to a variety of microbial hosts to enhance production of compounds spanning from biofuels to pharmaceuticals. In all cases metabolic… (more)

Subjects/Keywords: Biomedical engineering; Microbiology; Chemical engineering; Biofuels; Efflux transporters; Membrane transport; Microbial tolerance

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Boyarskiy, S. (2015). Small molecule membrane transporters for enhanced microbial production of biochemicals. (Thesis). University of California – Berkeley. Retrieved from http://www.escholarship.org/uc/item/2w31g4zc

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Boyarskiy, Sergey. “Small molecule membrane transporters for enhanced microbial production of biochemicals.” 2015. Thesis, University of California – Berkeley. Accessed March 07, 2021. http://www.escholarship.org/uc/item/2w31g4zc.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Boyarskiy, Sergey. “Small molecule membrane transporters for enhanced microbial production of biochemicals.” 2015. Web. 07 Mar 2021.

Vancouver:

Boyarskiy S. Small molecule membrane transporters for enhanced microbial production of biochemicals. [Internet] [Thesis]. University of California – Berkeley; 2015. [cited 2021 Mar 07]. Available from: http://www.escholarship.org/uc/item/2w31g4zc.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Boyarskiy S. Small molecule membrane transporters for enhanced microbial production of biochemicals. [Thesis]. University of California – Berkeley; 2015. Available from: http://www.escholarship.org/uc/item/2w31g4zc

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Manchester

6. Shajiei, Arezoo. INCREASED THERAPEUTIC INDEX OF TYROSINE KINASE INHIBITORS IN CML THROUGH MEMBRANE TRANSPORTER UPTAKE.

Degree: 2017, University of Manchester

 Chronic myeloid leukaemia (CML) is a hematopoietic stem cell disease, distinguished by the BCR-ABL gene and the presence of the Philadelphia chromosome. Recent studies have… (more)

Subjects/Keywords: Chronic myeloid leukaemia (CML); Maybridge Fragment (MBF); imatinib; influx or efflux transporters

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Shajiei, A. (2017). INCREASED THERAPEUTIC INDEX OF TYROSINE KINASE INHIBITORS IN CML THROUGH MEMBRANE TRANSPORTER UPTAKE. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:309621

Chicago Manual of Style (16th Edition):

Shajiei, Arezoo. “INCREASED THERAPEUTIC INDEX OF TYROSINE KINASE INHIBITORS IN CML THROUGH MEMBRANE TRANSPORTER UPTAKE.” 2017. Doctoral Dissertation, University of Manchester. Accessed March 07, 2021. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:309621.

MLA Handbook (7th Edition):

Shajiei, Arezoo. “INCREASED THERAPEUTIC INDEX OF TYROSINE KINASE INHIBITORS IN CML THROUGH MEMBRANE TRANSPORTER UPTAKE.” 2017. Web. 07 Mar 2021.

Vancouver:

Shajiei A. INCREASED THERAPEUTIC INDEX OF TYROSINE KINASE INHIBITORS IN CML THROUGH MEMBRANE TRANSPORTER UPTAKE. [Internet] [Doctoral dissertation]. University of Manchester; 2017. [cited 2021 Mar 07]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:309621.

Council of Science Editors:

Shajiei A. INCREASED THERAPEUTIC INDEX OF TYROSINE KINASE INHIBITORS IN CML THROUGH MEMBRANE TRANSPORTER UPTAKE. [Doctoral Dissertation]. University of Manchester; 2017. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:309621

7. Lê, Minh. L'apport de l'évaluation pharmacocinétique dans le choix des antirétroviraux (nature et dose) chez la personne vivant avec le VIH : Contribution of pharmacokinetic assessment in the selection of antiretroviral therapy (type and dose) in HIV-infected patients.

Degree: Docteur es, Epidémiologie et sciences de l'information biomédicale. Epidémiologie clinique, 2019, Sorbonne Paris Cité

En dépit des récentes avancées thérapeutiques, l’infection par le VIH pour être contrôlée nécessite le maintien à vie d’un traitement antirétroviral (ARV). De ce fait,… (more)

Subjects/Keywords: Compartiment profond; Pénétration séminale; Transporteurs d'efflux; HIV infection; Antiretroviral; Pharmacokinetic; Deep compartment; Seminal penetration; Drug-drug interaction; Efflux transporters

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lê, M. (2019). L'apport de l'évaluation pharmacocinétique dans le choix des antirétroviraux (nature et dose) chez la personne vivant avec le VIH : Contribution of pharmacokinetic assessment in the selection of antiretroviral therapy (type and dose) in HIV-infected patients. (Doctoral Dissertation). Sorbonne Paris Cité. Retrieved from http://www.theses.fr/2019USPCC020

Chicago Manual of Style (16th Edition):

Lê, Minh. “L'apport de l'évaluation pharmacocinétique dans le choix des antirétroviraux (nature et dose) chez la personne vivant avec le VIH : Contribution of pharmacokinetic assessment in the selection of antiretroviral therapy (type and dose) in HIV-infected patients.” 2019. Doctoral Dissertation, Sorbonne Paris Cité. Accessed March 07, 2021. http://www.theses.fr/2019USPCC020.

MLA Handbook (7th Edition):

Lê, Minh. “L'apport de l'évaluation pharmacocinétique dans le choix des antirétroviraux (nature et dose) chez la personne vivant avec le VIH : Contribution of pharmacokinetic assessment in the selection of antiretroviral therapy (type and dose) in HIV-infected patients.” 2019. Web. 07 Mar 2021.

Vancouver:

Lê M. L'apport de l'évaluation pharmacocinétique dans le choix des antirétroviraux (nature et dose) chez la personne vivant avec le VIH : Contribution of pharmacokinetic assessment in the selection of antiretroviral therapy (type and dose) in HIV-infected patients. [Internet] [Doctoral dissertation]. Sorbonne Paris Cité; 2019. [cited 2021 Mar 07]. Available from: http://www.theses.fr/2019USPCC020.

Council of Science Editors:

Lê M. L'apport de l'évaluation pharmacocinétique dans le choix des antirétroviraux (nature et dose) chez la personne vivant avec le VIH : Contribution of pharmacokinetic assessment in the selection of antiretroviral therapy (type and dose) in HIV-infected patients. [Doctoral Dissertation]. Sorbonne Paris Cité; 2019. Available from: http://www.theses.fr/2019USPCC020


University of Minnesota

8. Vaidhyanathan, Shruthi. Improving the Delivery of Molecularly-Targeted Agents to Effectively Treat Melanoma Brain Metastases.

Degree: PhD, Pharmaceutics, 2015, University of Minnesota

 The FDA approval of molecularly-targeted drugs that specifically targeted aberrant signaling proteins has brought about new hope for the treatment of advanced melanoma. Historically, metastatic… (more)

Subjects/Keywords: Breast cancer resistance protein; P-glycoprotein; Efflux transporters; brain distribution; Melanoma Brain Metastases; molecularly-targeted drugs; skin cancer; vemurafenib

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Vaidhyanathan, S. (2015). Improving the Delivery of Molecularly-Targeted Agents to Effectively Treat Melanoma Brain Metastases. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/191424

Chicago Manual of Style (16th Edition):

Vaidhyanathan, Shruthi. “Improving the Delivery of Molecularly-Targeted Agents to Effectively Treat Melanoma Brain Metastases.” 2015. Doctoral Dissertation, University of Minnesota. Accessed March 07, 2021. http://hdl.handle.net/11299/191424.

MLA Handbook (7th Edition):

Vaidhyanathan, Shruthi. “Improving the Delivery of Molecularly-Targeted Agents to Effectively Treat Melanoma Brain Metastases.” 2015. Web. 07 Mar 2021.

Vancouver:

Vaidhyanathan S. Improving the Delivery of Molecularly-Targeted Agents to Effectively Treat Melanoma Brain Metastases. [Internet] [Doctoral dissertation]. University of Minnesota; 2015. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/11299/191424.

Council of Science Editors:

Vaidhyanathan S. Improving the Delivery of Molecularly-Targeted Agents to Effectively Treat Melanoma Brain Metastases. [Doctoral Dissertation]. University of Minnesota; 2015. Available from: http://hdl.handle.net/11299/191424

9. Carrez, Romain. Implication in vivo des transporteurs pulmonaires sur la pharmacocinétique des anti-infectueux : In vivo involvement of pulmonary efflux transporters in the pharmacokinetics of anti-infectives agents.

Degree: Docteur es, Pharmacologie et sciences du médicament, 2019, Poitiers

 Face à la pénurie de nouveaux anti-infectieux et à l’émergence toujours plus importante d’agents infectieux multi-résistants, il est primordial de mieux utiliser l’arsenal thérapeutique à… (more)

Subjects/Keywords: Modélisation pharmacocinétique; Poumon; Transporteur d'efflux; Nébulisation oseltamivir; Oxazolidinones; Pharmacokinetics modeling; Lung; Efflux transporters; Nebulisation; Oseltamivir; Oxazolidinones; 615.792; 571.64; 573.25

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Carrez, R. (2019). Implication in vivo des transporteurs pulmonaires sur la pharmacocinétique des anti-infectueux : In vivo involvement of pulmonary efflux transporters in the pharmacokinetics of anti-infectives agents. (Doctoral Dissertation). Poitiers. Retrieved from http://www.theses.fr/2019POIT1803

Chicago Manual of Style (16th Edition):

Carrez, Romain. “Implication in vivo des transporteurs pulmonaires sur la pharmacocinétique des anti-infectueux : In vivo involvement of pulmonary efflux transporters in the pharmacokinetics of anti-infectives agents.” 2019. Doctoral Dissertation, Poitiers. Accessed March 07, 2021. http://www.theses.fr/2019POIT1803.

MLA Handbook (7th Edition):

Carrez, Romain. “Implication in vivo des transporteurs pulmonaires sur la pharmacocinétique des anti-infectueux : In vivo involvement of pulmonary efflux transporters in the pharmacokinetics of anti-infectives agents.” 2019. Web. 07 Mar 2021.

Vancouver:

Carrez R. Implication in vivo des transporteurs pulmonaires sur la pharmacocinétique des anti-infectueux : In vivo involvement of pulmonary efflux transporters in the pharmacokinetics of anti-infectives agents. [Internet] [Doctoral dissertation]. Poitiers; 2019. [cited 2021 Mar 07]. Available from: http://www.theses.fr/2019POIT1803.

Council of Science Editors:

Carrez R. Implication in vivo des transporteurs pulmonaires sur la pharmacocinétique des anti-infectueux : In vivo involvement of pulmonary efflux transporters in the pharmacokinetics of anti-infectives agents. [Doctoral Dissertation]. Poitiers; 2019. Available from: http://www.theses.fr/2019POIT1803


University of Manchester

10. Djoukhadar, Ibrahim Khalil. Measuring and Modifying Temozolomide Delivery in Brain Tumours.

Degree: 2017, University of Manchester

Glioblastoma (GBM) is the most common aggressive primary brain tumour in adults. Despite various recent treatment advances, prognosis and survival rates remain dismal. A potential… (more)

Subjects/Keywords: Brain Tumours; Neuro-oncology; Imaging; blood brain barrier; Temozolomide; efflux transporters; P-glycoprotein; Breast Cancer Resistance protein

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Djoukhadar, I. K. (2017). Measuring and Modifying Temozolomide Delivery in Brain Tumours. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:309634

Chicago Manual of Style (16th Edition):

Djoukhadar, Ibrahim Khalil. “Measuring and Modifying Temozolomide Delivery in Brain Tumours.” 2017. Doctoral Dissertation, University of Manchester. Accessed March 07, 2021. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:309634.

MLA Handbook (7th Edition):

Djoukhadar, Ibrahim Khalil. “Measuring and Modifying Temozolomide Delivery in Brain Tumours.” 2017. Web. 07 Mar 2021.

Vancouver:

Djoukhadar IK. Measuring and Modifying Temozolomide Delivery in Brain Tumours. [Internet] [Doctoral dissertation]. University of Manchester; 2017. [cited 2021 Mar 07]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:309634.

Council of Science Editors:

Djoukhadar IK. Measuring and Modifying Temozolomide Delivery in Brain Tumours. [Doctoral Dissertation]. University of Manchester; 2017. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:309634


University of Manchester

11. Djoukhadar, Ibrahim. Measuring and modifying Temozolomide delivery in brain tumours.

Degree: PhD, 2017, University of Manchester

 Glioblastoma (GBM) is the most common aggressive primary brain tumour in adults. Despite various recent treatment advances, prognosis and survival rates remain dismal. A potential… (more)

Subjects/Keywords: Breast Cancer Resistance protein; P-glycoprotein; efflux transporters; Temozolomide; Imaging; Neuro-oncology; Brain Tumours; blood brain barrier

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Djoukhadar, I. (2017). Measuring and modifying Temozolomide delivery in brain tumours. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/measuring-and-modifying-temozolomide-delivery-in-brain-tumours(5ffb33be-c2e9-4c2b-bd40-b3e439b2d8f8).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.822947

Chicago Manual of Style (16th Edition):

Djoukhadar, Ibrahim. “Measuring and modifying Temozolomide delivery in brain tumours.” 2017. Doctoral Dissertation, University of Manchester. Accessed March 07, 2021. https://www.research.manchester.ac.uk/portal/en/theses/measuring-and-modifying-temozolomide-delivery-in-brain-tumours(5ffb33be-c2e9-4c2b-bd40-b3e439b2d8f8).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.822947.

MLA Handbook (7th Edition):

Djoukhadar, Ibrahim. “Measuring and modifying Temozolomide delivery in brain tumours.” 2017. Web. 07 Mar 2021.

Vancouver:

Djoukhadar I. Measuring and modifying Temozolomide delivery in brain tumours. [Internet] [Doctoral dissertation]. University of Manchester; 2017. [cited 2021 Mar 07]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/measuring-and-modifying-temozolomide-delivery-in-brain-tumours(5ffb33be-c2e9-4c2b-bd40-b3e439b2d8f8).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.822947.

Council of Science Editors:

Djoukhadar I. Measuring and modifying Temozolomide delivery in brain tumours. [Doctoral Dissertation]. University of Manchester; 2017. Available from: https://www.research.manchester.ac.uk/portal/en/theses/measuring-and-modifying-temozolomide-delivery-in-brain-tumours(5ffb33be-c2e9-4c2b-bd40-b3e439b2d8f8).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.822947

12. Viana Soares, Ricardo. Study of the antiepileptic drugs transport through the immature blood-brain barrier : Etude du passage des médicaments antiépileptiques à travers la barrière hémato-encéphalique.

Degree: Docteur es, Pharmacologie, 2015, Sorbonne Paris Cité

La résistance aux médicaments antiépileptiques (MAEs) est un des problèmes majeurs des épilepsies infantiles, comme par exemple le syndrome de Dravet. La pharmacoresistance de l’épilepsie… (more)

Subjects/Keywords: Pharmacorésistance; Médicaments antiépileptiques; Syndrome de Dravet; Barrière hémato-encéphalique; Transporteurs d’efflux; Pharmacoresistance; Antiepileptic drugs; Dravet syndrome; Blood-brain barrier; Efflux transporters; 615.78

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Viana Soares, R. (2015). Study of the antiepileptic drugs transport through the immature blood-brain barrier : Etude du passage des médicaments antiépileptiques à travers la barrière hémato-encéphalique. (Doctoral Dissertation). Sorbonne Paris Cité. Retrieved from http://www.theses.fr/2015USPCB087

Chicago Manual of Style (16th Edition):

Viana Soares, Ricardo. “Study of the antiepileptic drugs transport through the immature blood-brain barrier : Etude du passage des médicaments antiépileptiques à travers la barrière hémato-encéphalique.” 2015. Doctoral Dissertation, Sorbonne Paris Cité. Accessed March 07, 2021. http://www.theses.fr/2015USPCB087.

MLA Handbook (7th Edition):

Viana Soares, Ricardo. “Study of the antiepileptic drugs transport through the immature blood-brain barrier : Etude du passage des médicaments antiépileptiques à travers la barrière hémato-encéphalique.” 2015. Web. 07 Mar 2021.

Vancouver:

Viana Soares R. Study of the antiepileptic drugs transport through the immature blood-brain barrier : Etude du passage des médicaments antiépileptiques à travers la barrière hémato-encéphalique. [Internet] [Doctoral dissertation]. Sorbonne Paris Cité; 2015. [cited 2021 Mar 07]. Available from: http://www.theses.fr/2015USPCB087.

Council of Science Editors:

Viana Soares R. Study of the antiepileptic drugs transport through the immature blood-brain barrier : Etude du passage des médicaments antiépileptiques à travers la barrière hémato-encéphalique. [Doctoral Dissertation]. Sorbonne Paris Cité; 2015. Available from: http://www.theses.fr/2015USPCB087

13. Wang, Jie. Fibroblast growth factor-2 protects neonatal rat cardiac myocytes from doxorubicin-induced damage via protein kinase C- dependent effects on efflux drug transporters.

Degree: Physiology, 2013, University of Manitoba

 Introduction: Therapeutic agents like doxorubicin, an anthracycline antibiotic drug, are widely used in cancer chemotherapy. The use of doxorubicin is limited however by an increased… (more)

Subjects/Keywords: FGF-2; Doxorubicin; efflux drug transporters; PKC; neonatal rat cardiomyocytes

…resistance mediated by efflux drug transporters. Strategies are needed to protect the heart and… …damage; and if so whether (2) an effect on efflux drug transporters might contribute… …Furthermore, inhibition of efflux drug transporters with CsA and Tariquidar (XR9576)… …7 Figure 1. 3 - ATP-binding cassette (ABC) efflux transporters… …multidrug resistance due to an increase in efflux drug transporters such as multidrug resistance… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wang, J. (2013). Fibroblast growth factor-2 protects neonatal rat cardiac myocytes from doxorubicin-induced damage via protein kinase C- dependent effects on efflux drug transporters. (Masters Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/18318

Chicago Manual of Style (16th Edition):

Wang, Jie. “Fibroblast growth factor-2 protects neonatal rat cardiac myocytes from doxorubicin-induced damage via protein kinase C- dependent effects on efflux drug transporters.” 2013. Masters Thesis, University of Manitoba. Accessed March 07, 2021. http://hdl.handle.net/1993/18318.

MLA Handbook (7th Edition):

Wang, Jie. “Fibroblast growth factor-2 protects neonatal rat cardiac myocytes from doxorubicin-induced damage via protein kinase C- dependent effects on efflux drug transporters.” 2013. Web. 07 Mar 2021.

Vancouver:

Wang J. Fibroblast growth factor-2 protects neonatal rat cardiac myocytes from doxorubicin-induced damage via protein kinase C- dependent effects on efflux drug transporters. [Internet] [Masters thesis]. University of Manitoba; 2013. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/1993/18318.

Council of Science Editors:

Wang J. Fibroblast growth factor-2 protects neonatal rat cardiac myocytes from doxorubicin-induced damage via protein kinase C- dependent effects on efflux drug transporters. [Masters Thesis]. University of Manitoba; 2013. Available from: http://hdl.handle.net/1993/18318


University of Minnesota

14. Li, Li. Active efflux transport and CNS distribution of the novel antifolate pemetrexed.

Degree: PhD, Pharmaceutics, 2010, University of Minnesota

 Pemetrexed (PMX, Alimta®) is a novel multi-targeted antifolate approved for the treatment of malignant pleural mesothelioma and non-small cell lung cancer (NSCLC). Given the high… (more)

Subjects/Keywords: Antifolate; Blood-Brain Barrier; Breast Cancer Resistance Protein; Efflux transporters; Pemetrexed; Pharmacokinetics; Pharmaceutics.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Li, L. (2010). Active efflux transport and CNS distribution of the novel antifolate pemetrexed. (Doctoral Dissertation). University of Minnesota. Retrieved from http://purl.umn.edu/61952

Chicago Manual of Style (16th Edition):

Li, Li. “Active efflux transport and CNS distribution of the novel antifolate pemetrexed.” 2010. Doctoral Dissertation, University of Minnesota. Accessed March 07, 2021. http://purl.umn.edu/61952.

MLA Handbook (7th Edition):

Li, Li. “Active efflux transport and CNS distribution of the novel antifolate pemetrexed.” 2010. Web. 07 Mar 2021.

Vancouver:

Li L. Active efflux transport and CNS distribution of the novel antifolate pemetrexed. [Internet] [Doctoral dissertation]. University of Minnesota; 2010. [cited 2021 Mar 07]. Available from: http://purl.umn.edu/61952.

Council of Science Editors:

Li L. Active efflux transport and CNS distribution of the novel antifolate pemetrexed. [Doctoral Dissertation]. University of Minnesota; 2010. Available from: http://purl.umn.edu/61952


INP Toulouse

15. Albérich, Mélanie. Impact de l'ivermectine sur les systèmes de détoxification des xénobiotiques : régulations chez l'hôte et chez le nématode : Impact of ivermectin on xenobiotic detoxification systems : regulations in host and nematode.

Degree: Docteur es, Pathologie, Toxicologie, Génétique et Nutrition, 2014, INP Toulouse

Les infections par les nématodes gastro-intestinaux entrainent des baisses en productions animales et des pertes économiques majeures pour les éleveurs. Les lactones macrocycliques (LMs) sont… (more)

Subjects/Keywords: Lactones macrocycliques anthelminthiques; Ivermectine; Transporteurs ABC d'efflux; Cytochromes P450; Foie; Intestin; Modèles murins; Caenorhabditis elegans; Récepteurs nucléaires; Flavonoïdes; Ivermectine aglycone; Résistance; Macrocyclic lactone; Ivermectin; ABC efflux transporters; Cytochromes; Liver; Intestine; Mice; Caenorhabditis elegans; Nuclear receptors; Flavonoïds; Ivermectin aglycone; Resistance

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Albérich, M. (2014). Impact de l'ivermectine sur les systèmes de détoxification des xénobiotiques : régulations chez l'hôte et chez le nématode : Impact of ivermectin on xenobiotic detoxification systems : regulations in host and nematode. (Doctoral Dissertation). INP Toulouse. Retrieved from http://www.theses.fr/2014INPT0102

Chicago Manual of Style (16th Edition):

Albérich, Mélanie. “Impact de l'ivermectine sur les systèmes de détoxification des xénobiotiques : régulations chez l'hôte et chez le nématode : Impact of ivermectin on xenobiotic detoxification systems : regulations in host and nematode.” 2014. Doctoral Dissertation, INP Toulouse. Accessed March 07, 2021. http://www.theses.fr/2014INPT0102.

MLA Handbook (7th Edition):

Albérich, Mélanie. “Impact de l'ivermectine sur les systèmes de détoxification des xénobiotiques : régulations chez l'hôte et chez le nématode : Impact of ivermectin on xenobiotic detoxification systems : regulations in host and nematode.” 2014. Web. 07 Mar 2021.

Vancouver:

Albérich M. Impact de l'ivermectine sur les systèmes de détoxification des xénobiotiques : régulations chez l'hôte et chez le nématode : Impact of ivermectin on xenobiotic detoxification systems : regulations in host and nematode. [Internet] [Doctoral dissertation]. INP Toulouse; 2014. [cited 2021 Mar 07]. Available from: http://www.theses.fr/2014INPT0102.

Council of Science Editors:

Albérich M. Impact de l'ivermectine sur les systèmes de détoxification des xénobiotiques : régulations chez l'hôte et chez le nématode : Impact of ivermectin on xenobiotic detoxification systems : regulations in host and nematode. [Doctoral Dissertation]. INP Toulouse; 2014. Available from: http://www.theses.fr/2014INPT0102


University of Queensland

16. Varasteh Moradi, Shayli. Improving the bioavailability and stability of luteinizing hormone-releasing hormone (LHRH) analogues.

Degree: School of Chemistry and Molecular Biosciences, 2015, University of Queensland

Subjects/Keywords: LHRH; Glycosylation; Peptide; Oral delivery; Prostate cancer; Glucose transporters; Efflux pump systems; Bioavailability; LH and FSH release; 0304 Medicinal and Biomolecular Chemistry; 1115 Pharmacology and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Varasteh Moradi, S. (2015). Improving the bioavailability and stability of luteinizing hormone-releasing hormone (LHRH) analogues. (Thesis). University of Queensland. Retrieved from http://espace.library.uq.edu.au/view/UQ:370230

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Varasteh Moradi, Shayli. “Improving the bioavailability and stability of luteinizing hormone-releasing hormone (LHRH) analogues.” 2015. Thesis, University of Queensland. Accessed March 07, 2021. http://espace.library.uq.edu.au/view/UQ:370230.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Varasteh Moradi, Shayli. “Improving the bioavailability and stability of luteinizing hormone-releasing hormone (LHRH) analogues.” 2015. Web. 07 Mar 2021.

Vancouver:

Varasteh Moradi S. Improving the bioavailability and stability of luteinizing hormone-releasing hormone (LHRH) analogues. [Internet] [Thesis]. University of Queensland; 2015. [cited 2021 Mar 07]. Available from: http://espace.library.uq.edu.au/view/UQ:370230.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Varasteh Moradi S. Improving the bioavailability and stability of luteinizing hormone-releasing hormone (LHRH) analogues. [Thesis]. University of Queensland; 2015. Available from: http://espace.library.uq.edu.au/view/UQ:370230

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Southern California

17. Bi, Lucun. Intracellular drug-drug interaction between nucleoside analogs leads to early virologic failure in HIV patients receiving triple nucleoside combinations of tenofovir, lamivudine and abacavir or didanosine.

Degree: PhD, Pharmaceutical Sciences, 2008, University of Southern California

 High level of virologic failure was observed in HIV patients receiving combinations of tenofovir (TFV), lamivudine (3TC) combined with either abacavir (ABC) or didanosine (ddI).… (more)

Subjects/Keywords: nucleoside analog; NRTI; intracellular drug-drug interaction; efflux transporters; MRP2; MRP4; cellular adaptive response; ddNTP; TFV; ABC; ddI; endogenous nucleotide pools; PNP

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bi, L. (2008). Intracellular drug-drug interaction between nucleoside analogs leads to early virologic failure in HIV patients receiving triple nucleoside combinations of tenofovir, lamivudine and abacavir or didanosine. (Doctoral Dissertation). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/47592/rec/3609

Chicago Manual of Style (16th Edition):

Bi, Lucun. “Intracellular drug-drug interaction between nucleoside analogs leads to early virologic failure in HIV patients receiving triple nucleoside combinations of tenofovir, lamivudine and abacavir or didanosine.” 2008. Doctoral Dissertation, University of Southern California. Accessed March 07, 2021. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/47592/rec/3609.

MLA Handbook (7th Edition):

Bi, Lucun. “Intracellular drug-drug interaction between nucleoside analogs leads to early virologic failure in HIV patients receiving triple nucleoside combinations of tenofovir, lamivudine and abacavir or didanosine.” 2008. Web. 07 Mar 2021.

Vancouver:

Bi L. Intracellular drug-drug interaction between nucleoside analogs leads to early virologic failure in HIV patients receiving triple nucleoside combinations of tenofovir, lamivudine and abacavir or didanosine. [Internet] [Doctoral dissertation]. University of Southern California; 2008. [cited 2021 Mar 07]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/47592/rec/3609.

Council of Science Editors:

Bi L. Intracellular drug-drug interaction between nucleoside analogs leads to early virologic failure in HIV patients receiving triple nucleoside combinations of tenofovir, lamivudine and abacavir or didanosine. [Doctoral Dissertation]. University of Southern California; 2008. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/47592/rec/3609

.